相似文献
1
O'nyong-nyong fever: a neglected mosquito-borne viral disease.
Pathog Glob Health. 2017 Sep;111(6):271-275. doi: 10.1080/20477724.2017.1355431. Epub 2017 Aug 22.
2
GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2: Epidemiological distribution of o'nyong-nyong virus.
Antiviral Res. 2019 Dec;172:104611. doi: 10.1016/j.antiviral.2019.104611. Epub 2019 Sep 20.
3
Development of a Real-Time Reverse Transcription Polymerase Chain Reaction for O'nyong-nyong Virus and Evaluation with Clinical and Mosquito Specimens from Kenya.
Am J Trop Med Hyg. 2017 Jul;97(1):121-124. doi: 10.4269/ajtmh.17-0027.
4
Vector competence of Anopheles stephensi for O'nyong-nyong virus: a risk for global virus spread.
Parasit Vectors. 2023 Apr 17;16(1):133. doi: 10.1186/s13071-023-05725-0.
5
GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 5: Entomological aspects.
Antiviral Res. 2020 Feb;174:104670. doi: 10.1016/j.antiviral.2019.104670. Epub 2019 Dec 5.
6
GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics.
Antiviral Res. 2019 Jun;166:66-81. doi: 10.1016/j.antiviral.2019.03.009. Epub 2019 Mar 21.
7
Pathogenicity and virulence of O'nyong-nyong virus: A less studied with pandemic potential.
Virulence. 2024 Dec;15(1):2355201. doi: 10.1080/21505594.2024.2355201. Epub 2024 May 26.
8
Determinants of Chikungunya and O'nyong-Nyong Virus Specificity for Infection of and Mosquito Vectors.
Viruses. 2023 Feb 21;15(3):589. doi: 10.3390/v15030589.
9
GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 3: Epidemiological distribution of Mayaro virus.
Antiviral Res. 2019 Dec;172:104610. doi: 10.1016/j.antiviral.2019.104610. Epub 2019 Sep 20.
10
Longitudinal [18F]FB-IL-2 PET Imaging to Assess the Immunopathogenicity of O'nyong-nyong Virus Infection.
Front Immunol. 2020 May 12;11:894. doi: 10.3389/fimmu.2020.00894. eCollection 2020.
引用本文的文献
1
Invasive is a competent vector for O'nyong Nyong virus.
One Health. 2025 May 4;20:101062. doi: 10.1016/j.onehlt.2025.101062. eCollection 2025 Jun.
2
First Phosphonic-Type Inhibitors and Activity-Based Probes Specific to the O'nyong-nyong Virus Capsid Protease.
ChemMedChem. 2025 Jun 17;20(12):e202500049. doi: 10.1002/cmdc.202500049. Epub 2025 Apr 18.
3
Alphavirus nsP2: A Multifunctional Regulator of Viral Replication and Promising Target for Anti-Alphavirus Therapies.
Rev Med Virol. 2025 Mar;35(2):e70030. doi: 10.1002/rmv.70030.
4
Seroprevalence of Chikungunya and O'nyong-nyong Viruses in Senegal, West Africa.
J Med Virol. 2025 Mar;97(3):e70282. doi: 10.1002/jmv.70282.
5
Distribution of Anophelinae (Diptera: Culicidae) and challenges for malaria elimination in Brazil.
Mem Inst Oswaldo Cruz. 2025 Feb 24;120:e240247. doi: 10.1590/0074-02760240247. eCollection 2025.
6
Neuropathogenesis of Old World Alphaviruses: Considerations for the Development of Medical Countermeasures.
Viruses. 2025 Feb 14;17(2):261. doi: 10.3390/v17020261.
7
Introduction of Vector-Borne Infections in Europe: Emerging and Re-Emerging Viral Pathogens with Potential Impact on One Health.
Pathogens. 2025 Jan 12;14(1):63. doi: 10.3390/pathogens14010063.
8
RT-RPA as a dual tool for detection and phylogenetic analysis of epidemic arthritogenic alphaviruses.
Sci Rep. 2024 Dec 3;14(1):30134. doi: 10.1038/s41598-024-81763-7.
9
High-Sensitivity RT-LAMP for Molecular Detection of O'nyong-nyong ().
Pathogens. 2024 Oct 11;13(10):892. doi: 10.3390/pathogens13100892.
10
Unraveling the complex interplay: immunopathology and immune evasion strategies of alphaviruses with emphasis on neurological implications.
Front Cell Infect Microbiol. 2024 Aug 15;14:1421571. doi: 10.3389/fcimb.2024.1421571. eCollection 2024.
本文引用的文献
1
Development of Vaccines for Chikungunya Fever.
J Infect Dis. 2016 Dec 15;214(suppl 5):S488-S496. doi: 10.1093/infdis/jiw271.
2
Comprehensive Genome Scale Phylogenetic Study Provides New Insights on the Global Expansion of Chikungunya Virus.
J Virol. 2016 Nov 14;90(23):10600-10611. doi: 10.1128/JVI.01166-16. Print 2016 Dec 1.
3
Seroepidemiology of selected arboviruses in febrile patients visiting selected health facilities in the lake/river basin areas of Lake Baringo, Lake Naivasha, and Tana River, Kenya.
Vector Borne Zoonotic Dis. 2015 Feb;15(2):124-32. doi: 10.1089/vbz.2014.1686.
4
High rates of o'nyong nyong and Chikungunya virus transmission in coastal Kenya.
PLoS Negl Trop Dis. 2015 Feb 6;9(2):e0003436. doi: 10.1371/journal.pntd.0003436. eCollection 2015 Feb.
5
O'nyong-nyong virus infection imported to Europe from Kenya by a traveler.
Emerg Infect Dis. 2014 Oct;20(10):1766-7. doi: 10.3201/eid2010.140823.
6
Prevalence of antibodies to alphaviruses and flaviviruses in free-ranging game animals and nonhuman primates in the greater Congo basin.
J Wildl Dis. 2013 Jul;49(3):587-99. doi: 10.7589/2012-08-212.
7
The role of innate versus adaptive immune responses in a mouse model of O'nyong-nyong virus infection.
Am J Trop Med Hyg. 2013 Jun;88(6):1170-9. doi: 10.4269/ajtmh.12-0674. Epub 2013 Apr 8.
8
O'nyong nyong virus molecular determinants of unique vector specificity reside in non-structural protein 3.
PLoS Negl Trop Dis. 2013;7(1):e1931. doi: 10.1371/journal.pntd.0001931. Epub 2013 Jan 24.
9
Silent circulation of arboviruses in Cameroon.
East Afr Med J. 2010 Jun;87(6):262-8. doi: 10.4314/eamj.v87i6.63085.
10
Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine.
Vaccine. 2012 Jun 29;30(31):4638-43. doi: 10.1016/j.vaccine.2012.04.099. Epub 2012 May 11.
Zotero 插件